
Last week, the Centers for Medicare & Medicaid Services (CMS) issued a press release to announce its decision to cover facial injections for Medicare beneficiaries who experience symptoms of depression due to the stigmatizing appearance of severely hollowed cheeks resulting from the drug treatment for Human Immunodeficiency Virus (HIV). The decision, that was announced on…






